pI: 6.9382 |
Length (AA): 775 |
MW (Da): 85695 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 11 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
29 | 352 | 1mky (A) | 43 | 363 | 16.00 | 0 | 0.98 | 0.56 | 0.22 |
84 | 351 | 1mky (A) | 87 | 362 | 20.00 | 0.0000000012 | 0.94 | 0.57 | -0.02 |
180 | 755 | 1g7s (A) | 4 | 583 | 20.00 | 0 | 1 | 0.39 | 0.71 |
183 | 340 | 2cxx (A) | 3 | 180 | 23.00 | 0.0000005 | 1 | 0.49 | -1.27 |
78 | 450 | 3mmp (A) | 163 | 1310 | 21.00 | 0 | 1 | 0.58059 | 0.55 |
106 | 375 | 1xzp (A) | 130 | 404 | 17.00 | 0 | 0.95 | 0.513687 | -0.26 |
111 | 584 | 4kjz (A) | 3 | 468 | 28.00 | 0 | 1 | 0.826913 | 0.69 |
120 | 457 | 4b3x (A) | 8 | 351 | 29.00 | 0.0000000023 | 1 | 0.815529 | -0.18 |
178 | 346 | 2lkc (A) | 5 | 173 | 49.00 | 0 | 1 | 0.879364 | -1.09 |
179 | 748 | 1g7r (A) | 3 | 583 | 20.00 | 0 | 1 | 0.606784 | 0.83 |
716 | 771 | 5hmo (A) | 825 | 883 | 38.00 | 0.56 | 0.05 | 0.468658 | -1.1 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | amastigotes, metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_127126)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G11160 | translation initiation factor IF-2 |
Arabidopsis thaliana | AT1G17220 | translation initiation factor IF-2 |
Babesia bovis | BBOV_II003130 | elongation factor Tu GTP binding domain containing protein |
Babesia bovis | BBOV_I003420 | elongation factor Tu GTP binding domain containing protein |
Brugia malayi | Bm1_34480 | Elongation factor Tu GTP binding domain containing protein |
Candida albicans | CaO19.12634 | Mitochondrial initiation factor 2 |
Candida albicans | CaO19_5167 | hypothetical protein |
Candida albicans | CaO19.5167 | Mitochondrial initiation factor 2 |
Caenorhabditis elegans | CELE_F46B6.6 | Protein F46B6.6, isoform A |
Chlamydia trachomatis | CT_096 | translation initiation factor IF-2 |
Dictyostelium discoideum | DDB_G0275751 | hypothetical protein |
Drosophila melanogaster | Dmel_CG12413 | CG12413 gene product from transcript CG12413-RA |
Escherichia coli | b3168 | translation initiation factor IF-2 |
Echinococcus granulosus | EgrG_000227400 | translation initiation factor IF 2 |
Echinococcus multilocularis | EmuJ_000227400 | translation initiation factor IF 2 |
Homo sapiens | ENSG00000085760 | mitochondrial translational initiation factor 2 |
Leishmania braziliensis | LbrM.22.1120 | translation initiation factor IF-2, putative |
Leishmania donovani | LdBPK_221060.1 | translation initiation factor IF-2, putative |
Leishmania infantum | LinJ.22.1060 | translation initiation factor IF-2, putative |
Leishmania major | LmjF.22.1240 | translation initiation factor IF-2, putative |
Leishmania mexicana | LmxM.22.1240 | translation initiation factor IF-2, putative |
Loa Loa (eye worm) | LOAG_01774 | elongation factor Tu GTP binding domain-containing protein |
Mycobacterium leprae | ML1556c | PROBABLE TRANSLATION INITIATION FACTOR IF-2 INFB |
Mus musculus | ENSMUSG00000020459 | mitochondrial translational initiation factor 2 |
Mycobacterium tuberculosis | Rv2839c | Probable translation initiation factor if-2 InfB |
Mycobacterium ulcerans | MUL_2122 | translation initiation factor IF-2 |
Neospora caninum | NCLIV_067450 | hypothetical protein |
Oryza sativa | 4339689 | Os05g0575300 |
Oryza sativa | 4347576 | Os09g0515500 |
Plasmodium berghei | PBANKA_0703600 | translation initiation factor IF-2, putative |
Plasmodium berghei | PBANKA_1231400 | sporozoite surface antigen MB2, putative |
Plasmodium falciparum | PF3D7_0516600 | sporozoite surface antigen MB2 |
Plasmodium falciparum | PF3D7_0827100 | translation initiation factor IF-2, putative |
Plasmodium knowlesi | PKNH_1321200 | translation initiation factor IF-2, putative |
Plasmodium knowlesi | PKNH_1016700 | translation initiation factor IF-2, putative |
Plasmodium vivax | PVX_080420 | MB2 protein, putative |
Plasmodium vivax | PVX_089010 | translation initiation factor IF-2, putative |
Plasmodium yoelii | PY03311 | Plasmodium falciparum MB2 |
Plasmodium yoelii | PY06191 | translation initiation factor IF-2 |
Saccharomyces cerevisiae | YOL023W | translation initiation factor 2 |
Schistosoma japonicum | Sjp_0211510 | ko:K02519 translation initiation factor IF-2, putative |
Schistosoma mansoni | Smp_167220 | mitochondrial translational initiation factor |
Schmidtea mediterranea | mk4.010079.01 | Translation initiation factor IF-2, mitochondrial |
Schmidtea mediterranea | mk4.004315.04 | Translation initiation factor IF-2, mitochondrial |
Trypanosoma brucei gambiense | Tbg972.7.3600 | translation initiation factor IF-2, putative |
Trypanosoma brucei | Tb927.7.3280 | translation initiation factor IF-2, putative |
Trypanosoma congolense | TcIL3000_7_2430 | translation initiation factor IF-2, putative |
Trypanosoma cruzi | TcCLB.511821.110 | translation initiation factor IF-2, putative |
Trypanosoma cruzi | TcCLB.510533.120 | translation initiation factor IF-2, putative |
Toxoplasma gondii | TGME49_278550 | elongation factor Tu GTP binding domain-containing protein |
Treponema pallidum | TP0891 | translation initiation factor IF-2 |
Theileria parva | TP04_0278 | hypothetical protein |
Theileria parva | TP03_0192 | translation initiation factor IF-2, putative |
Theileria parva | TP04_0279 | hypothetical protein |
Theileria parva | TP04_0280 | hypothetical protein |
Wolbachia endosymbiont of Brugia malayi | Wbm0537 | translation initiation factor IF-2 |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.7.3280 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.7.3280 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.7.3280 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.7.3280 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
b3168 | Escherichia coli | essential | goodall |
CELE_F46B6.6 | Caenorhabditis elegans | slow growth | wormbase |
PBANKA_1231400 | Plasmodium berghei | Slow | plasmo |
TGME49_278550 | Toxoplasma gondii | Probably essential | sidik |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.